Acute stroke thrombolysis in infective endocarditis.

Area of Science:

• Neurology
• Cardiology
• Infectious Diseases

Background:

• Intravenous recombinant tissue plasminogen activator (rt-PA) is a standard treatment for acute ischemic stroke.
• rt-PA is typically contraindicated in patients with infective endocarditis due to concerns about septic emboli and hemorrhagic transformation.
• Literature reports on rt-PA use in this specific patient population are scarce.

Observation:

• A patient presented with acute ischemic stroke.
• The patient was subsequently diagnosed with infective endocarditis.
• Despite the contraindication, the patient received intravenous rt-PA.

Findings:

• The patient experienced a successful outcome following rt-PA administration.
• This case represents a rare instance of successful rt-PA use in acute ischemic stroke with concurrent infective endocarditis.

Implications:

• This case challenges the absolute contraindication of rt-PA in select acute ischemic stroke patients with infective endocarditis.
• Further investigation into the safety and efficacy of rt-PA in similar complex cases may be warranted.
• Highlights the importance of considering individual patient factors in treatment decisions for acute stroke.